CRB's SlateXpace™ Gives Cell and Gene Therapy Clients New Flexibility, Control Over Manufacturing Needs To Support Highly Complex Product Pipelines
Emerging health threats, uncured diseases and the need to deliver critical therapies to patients are driving biotech companies to search for ways to build flexibility into their complex product pipelines and deliver projects in record time. Today, a pioneering multi-modality manufacturing solution addresses that challenge: SlateXpace™.
Assessing Climate Change Vulnerabilities on California Highways
Raging wildfires currently devastating the West Coast are a grim reminder of one of the vulnerabilities in the region intensified by climate change; impacting daily life and highlighting uncertainties of the reliability of critical highway infrastructure in the region.
Subscribe to